Prophylactic Total Gastrectomy: a Prospective Cohort Study of Long-Term Impact on Quality of Life
- PMID: 27752808
- DOI: 10.1007/s11605-016-3287-8
Prophylactic Total Gastrectomy: a Prospective Cohort Study of Long-Term Impact on Quality of Life
Abstract
Background: Hereditary diffuse gastric cancer (HDGC) syndrome is caused by germline mutations in the CDH1 gene and carries a lifetime gastric cancer risk of approximately 70 % in men and 56 % in women. Current consensus guidelines recommend that people of age ≥20 who harbor a CDH1 mutation undergo prophylactic total gastrectomy (PTG). However, the decision to proceed with a major visceral resection for prophylactic reasons may be difficult, especially since long-term outcomes are not well defined. We examined the decision-making process, physical symptoms, and psychosocial outcomes in adults who underwent PTG.
Methods: Participants completed pre- and post-operative questionnaires that included standardized measures of health-related quality of life (HRQOL), body image, psychological distress, regret, and decisional conflict. Those who declined surgery completed a questionnaire that measured decisional conflict and explored reasons for their choice.
Results: Forty of fifty (80 %) questionnaires distributed to 18 individuals were completed. In the 13 patients who underwent PTG, global HRQOL tended to decrease immediately post-operatively, climb to baseline by 6-12 months, then decrease again at 24 months. Body image and level of psychological distress remained relatively stable, and most patients expressed little decisional conflict or regret. All five individuals who declined surgery did so for practical reasons and would consider surgery in the future.
Conclusions: While most patients do not experience negative psychosocial consequences following PTG, mild physical symptoms persist and may affect long-term HRQOL. The present study emphasizes the need for long-term follow-up of this unique population of survivors.
Keywords: Body image; Decision-making; Gastrectomy; Quality of life; Stomach neoplasms.
Comment in
-
Decision making, quality of life and prophylactic gastrectomy in carriers of pathogenic CDH1 mutations.Transl Gastroenterol Hepatol. 2017 Mar 23;2:21. doi: 10.21037/tgh.2017.03.12. eCollection 2017. Transl Gastroenterol Hepatol. 2017. PMID: 28447056 Free PMC article. No abstract available.
Similar articles
-
Barriers and facilitators to CDH1 carriers contemplating or undergoing prophylactic total gastrectomy.Fam Cancer. 2021 Apr;20(2):157-169. doi: 10.1007/s10689-020-00197-y. Epub 2020 Aug 5. Fam Cancer. 2021. PMID: 32754788
-
An investigation of the factors effecting high-risk individuals' decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC).Fam Cancer. 2016 Oct;15(4):665-76. doi: 10.1007/s10689-016-9910-8. Fam Cancer. 2016. PMID: 27256430 Free PMC article.
-
Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in CDH1 Mutation Carriers.J Laparoendosc Adv Surg Tech A. 2021 Jul;31(7):729-737. doi: 10.1089/lap.2021.0239. Epub 2021 Jun 7. J Laparoendosc Adv Surg Tech A. 2021. PMID: 34097461
-
Global distribution of prophylactic total gastrectomy in E-cadherin (CDH1) mutations.Semin Oncol. 2022 Apr;49(2):130-135. doi: 10.1053/j.seminoncol.2022.03.001. Epub 2022 Mar 18. Semin Oncol. 2022. PMID: 35393124 Review.
-
Points to consider regarding prophylactic total gastrectomy in germline CDH1 variant carriers.J Surg Oncol. 2024 May;129(6):1082-1088. doi: 10.1002/jso.27603. Epub 2024 Feb 22. J Surg Oncol. 2024. PMID: 38389278 Review.
Cited by
-
A Systematic Review on Clinical and Health-Related Quality of Life Outcomes following Total Gastrectomy in Patients with Hereditary Diffuse Gastric Cancer.Cancers (Basel). 2024 Jan 23;16(3):473. doi: 10.3390/cancers16030473. Cancers (Basel). 2024. PMID: 38339225 Free PMC article. Review.
-
CDH1 Gene Mutation Hereditary Diffuse Gastric Cancer Outcomes: Analysis of a Large Cohort, Systematic Review of Endoscopic Surveillance, and Secondary Cancer Risk Postulation.Cancers (Basel). 2021 May 26;13(11):2622. doi: 10.3390/cancers13112622. Cancers (Basel). 2021. PMID: 34073553 Free PMC article.
-
Pioneering use of genetic analysis for CDH1 to identify candidates for prophylactic total gastrectomy to prevent hereditary diffuse gastric cancer.eGastroenterology. 2023 Sep;1(2):e100017. doi: 10.1136/egastro-2023-100017. Epub 2023 Dec 9. eGastroenterology. 2023. PMID: 38188186 Free PMC article.
-
Surgery for Hereditary Diffuse Gastric Cancer: Long-Term Outcomes.Cancers (Basel). 2022 Jan 30;14(3):728. doi: 10.3390/cancers14030728. Cancers (Basel). 2022. PMID: 35158993 Free PMC article.
-
Hereditary diffuse gastric cancer: cancer risk and the personal cost of preventive surgery.Fam Cancer. 2019 Oct;18(4):429-438. doi: 10.1007/s10689-019-00133-9. Fam Cancer. 2019. PMID: 31273560 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous